C
Christopher L. Jackson
Researcher at University of Bristol
Publications - 66
Citations - 5635
Christopher L. Jackson is an academic researcher from University of Bristol. The author has contributed to research in topics: Apolipoprotein E & Network topology. The author has an hindex of 25, co-authored 64 publications receiving 5219 citations.
Papers
More filters
Journal ArticleDOI
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
Morteza Naghavi,Peter Libby,Erling Falk,S. Ward Casscells,S. Ward Casscells,Silvio H. Litovsky,Silvio H. Litovsky,John A. Rumberger,Juan J. Badimon,Christodoulos Stefanadis,Pedro R. Moreno,Gerard Pasterkamp,Zahi A. Fayad,Peter Stone,Sergio Waxman,Paolo Raggi,Mohammad Madjid,Mohammad Madjid,Alireza Zarrabi,Alireza Zarrabi,Allen P. Burke,Chun Yuan,Peter J. Fitzgerald,David S. Siscovick,Chris L. de Korte,Masanori Aikawa,K.E. Juhani Airaksinen,Gerd Assmann,Christoph R. Becker,James H. Chesebro,Andrew Farb,Zorina S. Galis,Christopher L. Jackson,Ik-Kyung Jang,Wolfgang Koenig,Robert A. Lodder,Keith L. March,Jasenka Demirovic,Mohamad Navab,Silvia G. Priori,Mark D. Rekhter,Raymond D. Bahr,Scott M. Grundy,Roxana Mehran,Antonio Colombo,Eric Boerwinkle,Christie M. Ballantyne,William Insull,Robert S. Schwartz,Robert A. Vogel,Patrick W. Serruys,Göran K. Hansson,David P. Faxon,Sanjay Kaul,Helmut Drexler,Philip Greenland,James E. Muller,Renu Virmani,Renu Virmani,Paul M. Ridker,Douglas P. Zipes,Prediman K. Shah,James T. Willerson,James T. Willerson +63 more
TL;DR: The term "vulnerable patient" may be more appropriate and is proposed now for the identification of subjects with high likelihood of developing cardiac events in the near future and a quantitative method for cumulative risk assessment of vulnerable patients needs to be developed.
Journal ArticleDOI
Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries
TL;DR: It is demonstrated that MMPs are directly involved in atherosclerotic plaque destabilization and clearly show that members of the MMP family have widely differing effects on atherogenesis.
Journal ArticleDOI
Activation of Matrix-Degrading Metalloproteinases by Mast Cell Proteases in Atherosclerotic Plaques
TL;DR: In this article, the role of the mast cell proteases tryptase and chymase in activation of matrix-degrading metalloproteinases (MMPs) was investigated.
Journal ArticleDOI
Plaque Rupture After Short Periods of Fat Feeding in the Apolipoprotein E–Knockout Mouse Model Characterization and Effects of Pravastatin Treatment
Jason L. Johnson,Kevin G. S. Carson,Helen Williams,Sharada Karanam,Andrew C. Newby,Gianni D Angelini,Sarah J George,Christopher L. Jackson +7 more
TL;DR: Plaque rupture occurs at high frequency in the brachiocephalic arteries of male apolipoprotein E–knockout mice after 8 weeks of fat feeding and pravastatin treatment inhibits early plaque rupture and is also effective when begun after unstable plaques have developed.
Journal ArticleDOI
Characteristics of Intact and Ruptured Atherosclerotic Plaques in Brachiocephalic Arteries of Apolipoprotein E Knockout Mice
TL;DR: It is confirmed that plaque rupture is a frequent occurrence in the brachiocephalic arteries of apolipoprotein E knockout mice on a high-fat diet and the data show that ruptured plaques in these mice show many of the characteristics of vulnerable plaque in humans.